Testing effectiveness (Phase 2)Not Yet RecruitingNCT06586866
What this trial is testing
JK-1201I in Triple Negative Breast Cancer Patients with Brain Metastases
Who this might be right for
Triple Negative Breast Cancer (TNBC)Brain Metastasases
JenKem Technology Co., Ltd. 25